Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - RETAINED EARNINGS
Retained Earnings KALV - KalVista Pharmaceuticals, Inc.
-470 M
LAST VALUE
-37.03%
2 YEAR CAGR
-38.41%
5 YEAR CAGR
-29.87%
10 YEAR CAGR